pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON
Disc Medicine
Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 308
- Drugs
- 443
- Patents
- 706
IL-6 aGVHD Siltuximab: A phase II study to as...
Phase 2 · other · Grade III/IV acute graft versus host disease of the liver of/and the gastro-intestinal tract
IL-6 aGVHD Siltuximab: A phase II study to as... for Grade III/IV acute graft versus host disease of the liver of/and the gastro-intestinal tract is a Phase 2 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Disc Medicine
- Phase
- Phase 2
- Modality
- other
- Indication
- Grade III/IV acute graft versus host disease of the liver of/and the gastro-intestinal tract
- Status
- active
- Trials
- 1